Hisense HD60 Ultrasound Is Installation at Vaal Radiology, South Africa

Hisense, a manufacturer and provider of high-performance electronics and medical devices, has recently installed the Hisense Ultrasound HD60 at Vaal Radiology, a medical imaging center in Vereeninging, South Africa. This color Doppler ultrasound system is ideal for various ultrasound applications including general abdominal, vascular, and small parts.

“Hisense has established itself as a reliable brand globally through its R&D and clinical evaluations. The installation of the HD60 Ultrasound at Vaal Radiology is testament to the growing demand for Hisense’s cutting-edge, high-resolution, ultrasound devices in South Africa,” said Ronele Prince of Hisense.

Designed to provide clinicians with clearer, higher resolution imaging, the HD60 ultrasound system boasts advanced imaging algorithms and a GPU parallel architecture, which allow for faster processing of acoustic data and more precise imaging. Equipped with AI technology and comprehensive application packages, this system is the ideal tool for radiology ultrasound applications such as the abdomen, small parts, vascular, and more.

The Hisense Ultrasound HD60 is used in over 30 hospitals in China, facilitating over 50,000 diagnoses. In January 2022, Hisense received the SAHPRA license for the device in South Africa. In April 2022, Hisense secured its first order for a batch of Ultrasound HD60s in South Africa, marking a major milestone towards becoming a key player in the medical equipment sector.

Hisense has international certifications such as European Union CE MDR and American FDA, which have given the company access to the global medical device market. The company, through its ultrasound and medical display products, has a presence in many countries across the globe including the United Arab Emirates, Iraq, Indonesia, Thailand, Germany, Zimbabwe, Ghana as well as South Africa positioning it for continued growth in and beyond these regions.

Hisense is dedicated to delivering excellent products and services to its customers while fulfilling its healthcare mission. The company’s drive to innovate and enhance its offerings is unwavering. Through its state-of-the-art technology and continuous R&D, Hisense is proof of the scientific and technological strength of Chinese brands to users worldwide.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.